Trials / Completed
CompletedNCT00600509
Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
Bridging Study of L059(Levetiracetam) in Patients With Epilepsy by Double Blind Method
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Double-blind, randomized, placebo-controlled, multi center trial to evaluate the efficacy and safety of levetiracetam as adjunctive treatment in adult Japanese epileptic subjects with partial onset seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam |
Timeline
- Start date
- 2001-01-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2008-01-25
- Last updated
- 2013-09-17
Source: ClinicalTrials.gov record NCT00600509. Inclusion in this directory is not an endorsement.